All pharmaceutical companies |
|
|
|
|
|
|
|
Total payments , $
|
7,821,861
|
8,274,237
|
8,953,824
|
9,981,069
|
8,354,293
|
–
|
–
|
Payments per allergist
|
|
|
|
|
|
|
|
Mean (standard deviation), $
|
4,819 (11,395)
|
5,204 (12,305)
|
5,517 (12,200)
|
6,002 (13,243)
|
5,892 (13,200)
|
7.7 (5.0 – 10.6)*
|
-21.2 (-25.4 to -16.8)***
|
Median (interquartile range), $
|
1,332 (521 – 3,898)
|
1,435 (521 – 3,974)
|
1,526 (521 – 4,521)
|
1,535 (539 – 5,021)
|
1,518 (539 – 4,674)
|
|
|
Maximum, $
|
167,946
|
155,035
|
125,560
|
154,826
|
131,500
|
|
|
Physicians with payments (%), n
|
1623 (41.2)
|
1590 (40.3)
|
1623 (41.2)
|
1663 (42.2)
|
1418 (36.0)
|
0.9 (-0.1 to 2.1)
|
-14.8 (-17.9 to -11.5)***
|
Gini index
|
0.888
|
0.890
|
0.888
|
0.885
|
0.904
|
–
|
–
|
Pharmaceutical companies making payments throughout five years |
|
|
|
|
|
|
|
Total payments , $
|
7,645,832
|
8,192,889
|
8,710,193
|
9,653,679
|
8,144,163
|
–
|
–
|
Payments per allergist
|
|
|
|
|
|
|
|
Mean (standard deviation), $
|
4,782 (11,289)
|
5,208 (12,254)
|
5,468 (12,085)
|
6,015 (13,280)
|
5,919 (13,171)
|
7.2 (4.4 – 10.0)*
|
-20.4 (-24.6 to -15.9)*
|
Median (interquartile range), $
|
1,317 (521 – 3,873)
|
1448 (521 – 3,990)
|
1,526 (521 – 4,495)
|
1,564 (547 –4,931)
|
1,526 (539 – 4,666)
|
|
|
Maximum, $
|
166,980
|
155,035
|
125,560
|
154,826
|
130,757
|
|
|
Physicians with payments (%), n
|
1599 (40.6)
|
1573 (39.9)
|
1593 (40.4)
|
1605 (40.7)
|
1376 (34.9)
|
0.2 (-0.9 to 1.3)
|
-14.8 (-17.4 to -10.7)*
|
Gini index
|
0.889
|
0.891
|
0.889
|
0.889
|
0.906
|
–
|
–
|